Research output per year
Research output per year
Personal profile
Research
I defended my PhD-thesis at the Faculty of Medicine, Lund University, on the subject ” Health economics and its measures in rheumatoid arthritis” during December 2014. Research interests encompass rheumatoid arthritis, psoriatic arthritis and spondyloarthritis and focus on treatment outcomes, long-term disease outcomes, outcomes assessment, and health economics.
UKÄ subject classification
- Rheumatology and Autoimmunity
Keywords
- Rheumatoid arthritis
- Ankylosing spondylitis
- Psoriatic arthritis
- Spondyloarthritis
- Health economics
- biologic treatment
Fingerprint
Dive into the research topics where Johan Karlsson Wallman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
Hamberg, V., Wallman, J. K., Mogard, E., Lindqvist, E., Olofsson, T. & Andréasson, K., 2022, (Accepted/In press) In: Rheumatology International.Research output: Contribution to journal › Article › peer-review
Open Access -
Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
Sagard, J., Olofsson, T., Mogard, E., Marsal, J., Andréasson, K., Geijer, M., Kristensen, L. E., Lindqvist, E. & Wallman, J. K., 2022, In: Arthritis Research & Therapy. 24, p. 1-14 42.Research output: Contribution to journal › Article › peer-review
Open Access -
How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort
Lindqvist, E., Olofsson, T., Jöud, A., Geijer, M., Wallman, J. K. & Mogard, E., 2022, (Accepted/In press) In: Scandinavian Journal of Rheumatology.Research output: Contribution to journal › Article › peer-review
Open Access -
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
Glintborg, B., Lindström, U., Giuseppe, D. D., Provan, S. A., Gudbjornsson, B., Hetland, M. L., Michelsen, B., Wallman, J. K., Aaltonen, K., Hokkanen, A. M., Nordström, D., Jørgensen, T. S., Hansen, R. L., Geirsson, A. J., Grøn, K. L., Krogh, N. S., Askling, J., Kristensen, L. E. & Jacobsson, L. T. H., 2022 May, In: Arthritis Care and Research. 74, 5, p. 748-758 11 p.Research output: Contribution to journal › Article › peer-review
-
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration
Ørnbjerg, L. M., Linde, L., Georgiadis, S., Rasmussen, S. H., Lindström, U., Askling, J., Michelsen, B., Giuseppe, D. D., Wallman, J. K., Pavelka, K., Závada, J., Nissen, M. J., Jones, G. T., Relas, H., Pirilä, L., Tomšič, M., Rotar, Z., Geirsson, A. J., Gudbjornsson, B., Kristianslund, E. K., & 14 others, 2022 Oct 1, In: Seminars in Arthritis and Rheumatism. 56, 152081.Research output: Contribution to journal › Article › peer-review
Open Access
-
Psoriatic arthritis: Pain and remission in the biologic era
Palsson, O., C Kapetanovic, M., Karlsson Wallman, J., Einarsson, J. T., Gudbjornsson, B. & Love, T.
2017/05/01 → …
Project: Dissertation